Clinical trial
Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients
NCT02337335 is registered in ClinicalTrials.gov with NephroCare Spain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients
- Lead sponsor
- NephroCare Spain
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- April 30, 2015
- Enrollment
- 268 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.